MANGOCEUTICALS, INC.

MGRX Nasdaq CIK: 0001938046

Company Information

Industry Services-Misc Health & Allied Services, NEC
SIC Code 8090
Entity Type operating
SEC Category Emerging growth company
State of Incorporation TX
Business Address 15110 DALLAS PKWY, SUITE 600, DALLAS, TX, 75248
Mailing Address 15110 DALLAS PKWY, SUITE 600, DALLAS, TX, 75248
Phone (833) 626-4679
Fiscal Year End 1231
EIN 873841292

Financial Overview

FY2024 FY

$616K
Revenue
-$8.71M
Net Income
$13.95M
Stockholders' Equity

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events February 6, 2026 View on SEC
S-1/A IPO registration amendment January 23, 2026 View on SEC
S-1 IPO registration statement January 13, 2026 View on SEC
8-K Current report of material events December 19, 2025 View on SEC
424B5 Prospectus supplement December 19, 2025 View on SEC
8-K Current report of material events December 19, 2025 View on SEC
4 Insider stock transaction report December 17, 2025 View on SEC
4 Insider stock transaction report December 11, 2025 View on SEC
8-K Current report of material events December 10, 2025 View on SEC
4 Insider stock transaction report December 9, 2025 View on SEC

Material Events

8-K Financial Distress February 6, 2026
High Impact
  • MANGOCEUTICALS, INC. (MGRX) received a Nasdaq warning for consistently trading below the $1.00 minimum bid price, risking delisting.
  • The company has 180 calendar days, until August 3, 2026, to regain compliance with Nasdaq Listing Rule 5550(a)(2).
View Analysis

Insider Trading

SELL 2 insiders 4 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 8090)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.